news Developing a COVID-19 testing kit using RNA detection 20 March 2020 | By Hannah Balfour (Drug Target Review) The developers of an RNA imaging technology are using it to create a COVID-19 coronavirus testing kit, able to recognise the viral genome.
news CRISPR RNA-targeted genetic screen could be used for COVID-19 therapy 18 March 2020 | By Hannah Balfour (Drug Target Review) A new Cas13 RNA screen has been used to establish guide RNAs for the COVID-19 coronavirus and human RNA segments which could be used in vaccines, therapeutics and diagnostics.
news Collaboration to co-develop antibody products for treating COVID-19 17 March 2020 | By Victoria Rees (Drug Target Review) AbCellera and Eli Lilly have announced their partnership to develop, manufacture and distribute antibody treatments for the COVID-19 coronavirus.
news Mapping the immune response to COVID-19 17 March 2020 | By Hannah Balfour (Drug Target Review) Researchers reveal that a broad range of immune cells react to COVID-19 and aid recovery, findings which could inform the development of a potential vaccine.
news 3D visualisation of COVID-19 surface released for researchers 13 March 2020 | By Victoria Rees (Drug Target Review) A new 3D model of the surface of the coronavirus COVID-19 has been released, to aid researchers in the development of a treatment.
news Researchers work to create a COVID-19 viral epitope map 13 March 2020 | By Hannah Balfour (Drug Target Review) The team used data from SARS-CoV to identify possible viral epitopes that vaccines could include to stimulate an immune response.
article Using virtual screening to identify coronavirus treatments 10 March 2020 | By Victoria Rees (Drug Target Review) Drug Target Review rounds up the latest updates on research into coronavirus treatments, focusing on virtual screening to find therapies for COVID-19.
news Scientists demonstrate how COVID-19 infects human cells 5 March 2020 | By Hannah Balfour (Drug Target Review) Researchers have used cryogenic electron microscopy to show that coronaviruses enter human cells through an interaction with angiotensin-converting enzyme 2 (ACE2).
news Researchers map vital atomic-scale protein on COVID-19 20 February 2020 | By Victoria Rees (Drug Target Review) Using cryogenic electron microscopy, a team has mapped the Spike protein on COVID-19, which could be used in the development of vaccines.